Product Images Vivelle Dot
View Photos of Packaging, Labels & Appearance
- image of 0.05 mg package label - 4242
- image of 0.75 mg package label - 4243
- image of 0.1 mg package label - 4244
- image of 0.0375 mg package label - 4920
- Estradiol structural formula - vivelle dot 02
- Vivelle-Dot layer image - vivelle dot 03
- Figure 1Steady State Estradiol Plasma Concentrations for Systems Applied to the AbdomenNonbaseline corrected levels - vivelle dot 04
- Figure 2 Mean (SD) change from baseline in mean daily number of flushes for Vivelle® 0.0375 mg versus Placebo in a 12 week trial. - vivelle dot 05
- Figure 3 Bone mineral density AP Lumbar spine Least squares means of percentage change from baseline All randomized patients with at least one post baseline assessment available with last post baseline observation carried forward - vivelle dot 06
- Figure 4 Bone mineral density Femoral neck Least squares means of percentage change from baseline All randomized patients with at least one post baseline assessment available with last post baseline observation carried forward - vivelle dot 07
- Determine Your Schedule for Your Twice-a-Week Application - vivelle dot 08
- Where to Apply Vivelle-Dot® - vivelle dot 09
- Before You Apply Vivelle-Dot® - vivelle dot 0A
- How to Apply Vivelle-Dot® 1 - vivelle dot 0B
- How to Apply Vivelle-Dot® 2 - vivelle dot 0C
- How to Apply Vivelle-Dot® 3 - vivelle dot 0D
- How to Apply Vivelle-Dot® 4 - vivelle dot 0E
- How to Apply Vivelle-Dot® 5 - vivelle dot 0F
- How to Apply Vivelle-Dot® 6 - vivelle dot 10
Product Label Images
The following 19 images provide visual information about the product associated with Vivelle Dot NDC 54868-4920 by Physicians Total Care, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
image of 0.05 mg package label - 4242

This is a description of a medical product called VIVELLE-DOT TRNSDR, which is distributed by PHYSICIANS TOTAL CARE. The product is a patch that contains 0.85mg of medication and there are 8 patches in one package (NDC 54868-4242-0). The lot number is 0000 and the expiration date is 01/60. The rest of the text is not legible.*
image of 0.75 mg package label - 4243

This is a medication product called VIVELLE-DOT TRHSDR 6.075 HG PAT, distributed by PHYSICIANS TOTAL CARE with a National Drug Code (NDC) of 54868-4243-0. The package contains 8 units and a lot number which is followed by an expiration date. The last line with the number "42430080000" is not clear and it is difficult to determine its meaning or relevance to the product description.*
image of 0.1 mg package label - 4244

Vivelle-Dot Transdermal System is distributed by Physicians Total Care and has an NDC 54868-4244-6. The medication is in the form of a patch containing 0.11g and has a Lot No. of 000, with an expiration date of 01/60. The remaining text is not clear to form a complete description.*
image of 0.0375 mg package label - 4920

This is a description of a pack of eight VIVELLE-DOT TRNSDR 8. 6375 PAT hormone patches, distributed by PHYSICIANS TOTAL CARE. The NDC (National Drug Code) is 54868-4920-0 and the lot number is ¥ 0008 with the expiration date of 01/60. The rest of the text seems to be unreadable and contains non-English characters.*
Figure 1Steady State Estradiol Plasma Concentrations for Systems Applied to the AbdomenNonbaseline corrected levels - vivelle dot 04

Figure 2 Mean (SD) change from baseline in mean daily number of flushes for Vivelle® 0.0375 mg versus Placebo in a 12 week trial. - vivelle dot 05

Figure 3 Bone mineral density AP Lumbar spine Least squares means of percentage change from baseline All randomized patients with at least one post baseline assessment available with last post baseline observation carried forward - vivelle dot 06

This is a table showing the percentage change from baseline in a treatment duration for different doses of Vivelle, which is a medication available in several strengths measured in milligrams per day. The data is presented for three different points in time: Week 52, Week 78, and Week 104. There are five different strength options, including a placebo.*
Figure 4 Bone mineral density Femoral neck Least squares means of percentage change from baseline All randomized patients with at least one post baseline assessment available with last post baseline observation carried forward - vivelle dot 07

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.